Literature DB >> 6327943

Analysis of radioimmunodetection of tumors by the subtraction technique.

A J Green, R H Begent, P A Keep, K D Bagshawe.   

Abstract

The subtraction method for radioimmunodetection (RID) of cancer is showing potential as a diagnostic tool. An objective assessment of this technique is needed in order to determine its clinical usefulness. A numerical analysis of the RID scintigrams was developed and applied to 21 RID studies on 20 patients for whom a final diagnosis had been established. The subtraction technique was shown to give rise to artifactual positive regions, which could be avoided by experienced clinicians. When artifact-producing regions were excluded, 97 regions were examined (80 nontumor, 17 tumor-containing). The "background" scintigrams were shown to be good models for nontumor regions of the antibody scintigrams, and tumor and nontumor regions were shown to form statistically distinct groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327943

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  A new approach to image subtraction in immunoscintigraphy: preliminary results.

Authors:  J C Liehn; P Hannequin; S Nasca; D Lebrun; A Cattan; J Valeyre
Journal:  Eur J Nucl Med       Date:  1987

3.  Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice.

Authors:  M K Haseman; D A Goodwin; C F Meares; M S Kaminski; T G Wensel; M J McCall; R Levy
Journal:  Eur J Nucl Med       Date:  1986

4.  Gamma camera emission tomography using radiolabelled antibodies.

Authors:  A C Perkins; D R Whalley; K C Ballantyne; M V Pimm
Journal:  Eur J Nucl Med       Date:  1988

5.  Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2).

Authors:  P C Jackson; E M Pitcher; J O Davies; E R Davies; C S Sadowski; G E Staddon; G M Stirrat; C A Sunderland
Journal:  Eur J Nucl Med       Date:  1985

6.  The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma.

Authors:  R H Begent; K D Bagshawe; A J Green; F Searle
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.